Poly-methyl pentene oxygenators have improved gas exchange capability and reduced transfusion requirements in adult extracorporeal membrane oxygenation

ASAIO Journal

Volumn 51, Issue 3, 2005, Pages 281-287

  Khoshbin, Espeed ^a   Roberts, Neil ^b   Harvey, Chris ^b   Machin, David ^b   Killer, Hilliary ^b   Peek, Giles J ^b   Sosnowski, Andrzej W ^b   Firmin, Richard K ^b  

^a UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BIOMEDICAL ENGINEERING; BLOOD; BLOOD GAS ANALYSIS; COAGULATION; HEAT EXCHANGERS; HYDROCARBONS; PATIENT MONITORING; PHYSIOLOGY;

BLOOD PATH; BLOOD TRANSFUSION; COAGULATION FACTORS; GAS EXCHANGE; RED BLOOD CELLS;

OXYGENATORS;

BLOOD CLOTTING FACTOR;

ADULT; ARTICLE; BLOOD CLOT; BLOOD FLOW; BLOOD TRANSFUSION; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; ERYTHROCYTE; EXTRACORPOREAL OXYGENATION; FEMALE; GAS EXCHANGE; HEAT EXCHANGE; HUMAN; MALE; OXYGENATOR; POLY METHYL PENTENE OXYGENATOR; SILICONE MEMBRANE OXYGENATOR; THROMBOCYTE;

ADULT; AGED; BLOOD COAGULATION; BLOOD TRANSFUSION; EXTRACORPOREAL MEMBRANE OXYGENATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PRESSURE; PULMONARY GAS EXCHANGE; REFERRAL AND CONSULTATION; RETROSPECTIVE STUDIES;

EID: 18744407012     PISSN: 10582916     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.MAT.0000159741.33681.F1     Document Type: Article

References (29)

1. Buchwald D: Extrakorporeale membraoxygenation bei erwachsenen patientten, in Tschaut RJ (ed), Extrakorporale Zirkulation in Theorie und Praxis, Lengerich, Germany: Pabst Science Publishers, 1999, S. 567-589.
2. Henseler A, Oedekoven B, Mottaghy K: Differenzierte Betrachtung der Druckverhaltnisse in Membranoxygenatoren und Warmetauschern. Kardiotechnik 9: 42-46, 2000.
3. Khoshbin E, Westrope C, Pooboni S, et al: Performance of Polymethyl pentene oxygenators for neonatal extra-corporeal membrane oxygenation: A comparison with silicon membrane oxygenators. Perfusion 2004 (in press).
4. Peek GJ, Killer HM, Reeves R, Sosnowski AW, Firmin RK: Early experience with a poly-methyl pentene oxygenator for adult extracorporeal life support. ASAIO J 48: 480-482, 2002.
5. Peek GJ, Firmin RK: The inflammatory and coagulative response to prolonged extracorporeal membrane oxygenation. ASAIO J 45: 250-263, 1999.
6. Mueller X, Tevaearai H, Jegger D, Boone Y, Augstburger M, von Segesser L: Impact of hollow-fiber membrane surface area on oxygenator performance: Dideco D903 Avant versus a prototype with larger surface area. J Extra Corpor Technol 32: 152-157, 2000.
7. Bramson ML, Osborn JJ, Main FB, O'Brian MF, Wright JS, Gerbode F: A new disposable membrane oxygenator with integral heat exchange. J Thoracic Cardiovasc Surg 50: 391-400, 1965.
8. Beckley PD, Holt DW, Tallman JR: Oxygenator for extracorporeal circulation, in Mora CT, Guyton RA, Finlayson DC, Rigatti RL (eds), Cardiopulmonary Bypass, Principals and Techniques of Extracorporeal Circulation. New York: Springer Verlag, 1995, pp. 199-219.
9. Ovrum E, Tangen G, Oystese R, Ringdal MA, Istad R: Heparin-coated circuits (Duraflo II) with reduced versus full anticoagulation during coronary artery bypass surgery. J Card Surg 18: 140-146, 2003.
10. Tong SD, Rolfs MR, Hsu LC: Evaluation of Duraflo II heparin immobilized cardiopulmonary bypass circuits. Trans ASAIO 36: M654-656, 1990.
11. Pradhan MJ, Fleming JS, Nkere UU, Arnold J, Wildevuur ChRH, Taylor KM: Clinical experience with heparin coated cardiopulmonary bypass circuit. Perfusion 6: 235-242, 1991.
12. Ranucci M, Cazzaniga A, Soro G, Isgro G, Frigiola A, Menicanti L: The antithrombin III-saving effect of reduced systemic heparinization and heparin-coated circuits. J Cardiothorac Vasc Anesth 6: 316-320, 2002.
13. Svenmarker S, Sandstrom E, Karlsson T, et al: Neurological and general outcome in low-risk coronary artery bypass patients using heparin coated circuits. Eur J Cardiothorac Surg 19: 47-53, 2001.
14. Beckley P, Morris SM, Smith JJ, Mcnamara JL, Novak JA: Comparison of the characteristics of three generations of membrane oxygenators: The Univox, Univox Gold and Spiral Gold. Perfusion 11: 61-70, 1996.
15. Videm V, Mollnes TE, Garred P, et al: Biocompatibility of extracorporeal circulation: In vitro comparison of heparin coated and uncoated oxygenator circuits. J Thoracic Cardiovasc Surg 101: 654-660, 1999.
16. Videm V, Svennevig JL, Fosse E, et al: Reduced compliment activation with heparine coated oxygenator and tubings in coronary bypass operations. J Thorac Cardiovasc Surg 103: 806-813, 1992.
17. Pekna M, Hagman L, Halden E, et al: Complement activation during cardiopulmonary bypass: Effects of immobilized heparin. Ann Thorac Surg 58: 421-424, 1994.
18. Ovrum E, Mollnes TE, Fosse E, et al: High and low heparin dose with heparin-coated cardiopulmonary bypass: Activation of complement and granulocytes. Ann Thorac Surg 60: 1755-1761, 1995.
19. Plotz FB, Van Oeveren W, Hultquist KA, et al: A heparin-coated circuit reduces complement activation and the release of leukocyte inflammatory mediators during extracorporeal circulation in a rabbit. Artif Organs 16: 366-370, 1992.
20. te Velthuis H, Jansen PGM, Hack CE, et al: Specific complement inhibition with heparin coated extracorporeal circuits. Ann Thorac Surg 61: 1153-1157, 1996.
21. Fosse E, Moen O, Johnson E, et al: Reduced complement and granulocyte activation with heparin-coated cardiopulmonary bypass. Ann Thorac Surg 58: 472-477, 1994.
22. Brovic J, Thelin S, Bagge L, et al: Heparin coated circuits reduce activation of granulocytes during cardiopulmonary bypass: a clinical study. J Thorac Cardiovasc Surg 104: 642-47, 1992.
23. Gorman RC, Ziats NP, Rao AK, et al: Surface bound heparin fails to reduce thrombin formation during clinical cardiopulmonary bypass. J Thorac Cardiovasc Surg 111: 1-12, 1996.
24. Hatori N, Yoshizu H, Haga Y, et al: Biocompatibility of heparin coated- membrane oxygenator during cardiopulmonary bypass. Artif Organs 18: 904-910, 1994.
25. Gu YJ, van Oeveren W, Akkerman C, et al: Heparin coated circuits reduce the inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 55: 917-922, 1993.
26. Redmond JM, Gilinov AM, Stuart RS, et al: Heparin coated bypass circuits reduce pulmonary injury. Ann Thorac Surg 56: 474-479, 1993.
27. Weewind PW, Maessen JG, van Tits LJH, et al: Influence of Duraflo II heparin-treated extracorporeal circuits on the systemic inflammatory response in patients having coronary bypass. J Thorac Cardiovasc Surg 110: 1633-1641, 1995.
28. Stallion A, Cofer B, Rafferty JA, Ziegler MM, Ryckman FC: The significant relationship between platelet count and haemorrhagic complications on ECMO. Perfusion 9: 265-269, 1994.
29. Ranucci M, Cirri S, Conti D, et al: Beneficial effects of Duraflo II heparin- coated circuits on post perfusion lung dysfunction. Ann Thorac Surg 61: 76-81, 1996.